Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Veterinary Hematology Analyzers Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Analysis Parameter, End-user, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 21405| Published Date: Jul-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Veterinary Hematology Analyzers Market size stood at USD 149.2 Million in 2026 and is predicted to grow at 16.33% CAGR from 2027 to 2036, exceeding USD 677.15 Million by 2036. The industry revenue for 2027 is calculated at USD 170.28 Million.

Base Year Value (2026)
USD 149.2 Million
CAGR (2027-2036)
16.33%
Forecast Year Value (2036)
USD 677.15 Million
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Veterinary Hematology Analyzers Market Intelligence Snapshot

Regional Market Dynamics

  • North America led in 2026 due to advanced veterinary infrastructure, widespread diagnostic services, automated laboratory adoption, and growing emphasis on preventive animal care.
  • Asia Pacific is projected to grow fastest as pet ownership, veterinary spending, specialized animal hospitals, and automated diagnostic equipment adoption increase.

Segment Momentum

  • Companion animals accounted for 80.85% share in 2026, driven by rising pet healthcare spending, preventive diagnostics, and increased demand for routine animal health monitoring.
  • Point-of-care testing is growing as veterinarians seek faster results, improved treatment decisions, and compact analyzers that enhance clinical efficiency.

Market Expansion Drivers

  • Increasing animal healthcare expenditure driving advanced diagnostic adoption
  • Rising clinical visits and routine bloodwork boosting diagnostic analyzer demand
  • Expansion of veterinary diagnostic laboratories and specialty animal hospitals

Leading Market Participants

  • Key players in the veterinary hematology analyzers market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Sysmex Corporation (Japan), Horiba, Ltd. (Japan), Boule Diagnostics AB (Sweden), Heska Corporation (United States), HemoCue AB (Sweden), Shenzhen Mindray Animal Medical Technology Co., Ltd. (China), Siemens Healthineers AG (Germany)

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 149.2 Million
  • 2027 Estimated Market Size: USD 170.28 Million
  • Projected Market Size: USD 677.15 Million by 2036
  • Growth Forecast: 16.33% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Companion Animals (Animal Type) | 3-Part WBC Differential (Analysis Parameter) | Veterinary Hospitals & Clinics (End-user) | Table-Top Analyzers (Product)
  • Emerging Opportunity Segment: Companion Animals (Animal Type) | 5-Part WBC Differential (Analysis Parameter) | Point-of-care Testing (End-user) | Point-of-care Analyzers (Product)
Market Dynamics

Market Growth Drivers and Industry Trends

Increasing animal healthcare expenditure driving advanced diagnostic adoption

Growing investment in companion animal and livestock healthcare is encouraging veterinary providers to adopt sophisticated diagnostic technologies that support faster and more accurate clinical decision-making. The veterinary hematology analyzers market growth is driven by increasing animal healthcare expenditure, enabling clinics and hospitals to invest in automated analyzers capable of delivering comprehensive blood analysis with improved efficiency. As pet owners place greater emphasis on preventive care and livestock producers seek enhanced herd health management, veterinary practices are expanding their diagnostic capabilities to improve disease detection, treatment planning, and routine health assessments.

Rising clinical visits and routine bloodwork boosting diagnostic analyzer demand

The increasing frequency of veterinary consultations for preventive care, chronic disease management, and preoperative evaluations is contributing to higher demand for routine laboratory testing. Rising clinical visits and regular blood examinations will propel the veterinary hematology analyzers market growth by expanding the need for reliable hematological testing across companion animal clinics, specialty practices, and mixed-animal facilities. Automated analyzers enable veterinarians to obtain rapid and standardized blood profiles that support timely diagnosis while improving workflow efficiency in busy clinical environments.

Expansion of veterinary diagnostic laboratories and specialty animal hospitals

The continued development of dedicated veterinary diagnostic laboratories and specialized animal healthcare centers is strengthening access to advanced laboratory services across a wider range of animal species. Expansion of these healthcare facilities will boost the veterinary hematology analyzers market demand by increasing investments in high-performance diagnostic equipment capable of handling larger testing volumes with consistent analytical accuracy. The growing availability of specialized laboratory infrastructure also supports more comprehensive diagnostic services, facilitating collaboration between veterinary practitioners and reference laboratories for complex case evaluations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing animal healthcare expenditure driving advanced diagnostic adoption 2.6% Moderate North America, Europe High Near Term
Rising clinical visits and routine bloodwork boosting diagnostic analyzer demand 2.4% Moderate North America, Asia Pacific, Europe High Near Term
Expansion of veterinary diagnostic laboratories and specialty animal hospitals 2.3% Moderate North America, Europe, Asia Pacific Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Veterinary Hematology Analyzers Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America dominated the veterinary hematology analyzers market in 2026, reflecting its advanced veterinary healthcare infrastructure, widespread availability of diagnostic services, and strong adoption of automated laboratory technologies. Growing companion animal ownership and increasing emphasis on preventive veterinary care are encouraging more routine blood testing, while sophisticated veterinary hospitals and diagnostic facilities support the use of hematology analyzers for faster and more consistent clinical assessment.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is positioned for the fastest growth as veterinary healthcare capabilities expand and awareness of animal health diagnostics continues to improve. Rising pet ownership, increasing expenditure on veterinary services, development of specialized animal hospitals, and greater adoption of automated diagnostic equipment are creating favorable conditions for wider analyzer utilization across both companion and livestock healthcare settings.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

United States 🇺🇸

Companion Care Diagnostics

The U.S. invests in veterinary hematology analyzers that support rapid blood testing across companion animal clinics and specialty hospitals. Veterinary practices prioritize workflow efficiency, diagnostic accuracy, and integrated laboratory solutions.

Germany 🇩🇪

Precision Veterinary Testing

Germany focuses on veterinary hematology analyzers that deliver reliable diagnostic performance for companion and livestock healthcare. Laboratories and veterinary clinics emphasize automation, quality assurance, and consistent analytical results.

Japan 🇯🇵

Automated Laboratory Systems

Japan advances veterinary hematology analyzers with compact automated platforms suitable for modern veterinary practices. Clinics prioritize efficient testing, reduced sample handling, and dependable diagnostic support for routine animal care.

South Korea 🇰🇷

Smart Veterinary Diagnostics

South Korea strengthens veterinary diagnostic capabilities through adoption of advanced hematology analyzers. Animal healthcare providers seek systems with digital connectivity, rapid reporting, and reliable performance across diverse clinical settings.

France 🇫🇷

Clinical Laboratory Expansion

France expands veterinary hematology analyzer deployment in diagnostic laboratories and veterinary hospitals. The country emphasizes accurate blood analysis that supports preventive care, disease monitoring, and improved clinical decision-making.

Italy 🇮🇹

Veterinary Practice Modernization

Italy modernizes veterinary services through increased use of hematology analyzers in companion animal clinics and mixed veterinary practices. Healthcare providers value compact systems that improve diagnostic turnaround while supporting routine laboratory testing.

Segment Analysis

Segment Leadership and Growth Trends

Veterinary Hematology Analyzers Market Share (%), by Animal Type, 2026

Companion Animals
Livestock animals

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Animal Type Segment Analysis: Companion Animals (Largest & Fastest-Growing Segment)

The companion animals segment dominated the veterinary hematology analyzers market with an 80.85% share in 2026 and is also the fastest-growing segment. Rising pet ownership, increasing expenditure on animal healthcare, and growing awareness regarding preventive veterinary diagnostics have significantly contributed to its leadership. Companion animals frequently undergo routine health assessments, disease monitoring, and diagnostic testing, driving consistent demand for hematology analyzers. The increasing tendency among pet owners to seek advanced medical care for animals, combined with ongoing improvements in veterinary diagnostic capabilities, continues to strengthen the segment’s growth outlook.

Analysis Parameter Segment Analysis: 3-Part WBC Differential (Largest Segment) vs 5-Part WBC Differential (Fastest-Growing Segment)

The 3-part WBC differential segment accounted for a 50.56% share in 2026, making it the largest category within the veterinary hematology analyzers market. Its widespread adoption is driven by operational simplicity, cost-effectiveness, and suitability for routine diagnostic testing in veterinary practices. Many clinics rely on 3-part differential systems for everyday blood analysis because they provide essential hematological information while maintaining efficient workflows and manageable operating costs.

The 5-part WBC differential segment is witnessing the fastest growth as veterinary professionals increasingly seek more detailed and comprehensive diagnostic insights. Advanced differentiation capabilities enable improved detection and monitoring of complex health conditions, supporting more accurate clinical decision-making. As veterinary medicine continues to evolve toward higher diagnostic precision, demand for 5-part differential analyzers is expected to expand steadily.

End-user Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs Point-of-care Testing (Fastest-Growing Segment)

The veterinary hospitals and clinics segment held the largest share in 2026 due to the high volume of diagnostic procedures performed in these settings. These facilities routinely utilize hematology analyzers for disease diagnosis, treatment monitoring, and preventive health assessments. The presence of trained veterinary professionals and access to comprehensive diagnostic infrastructure have supported the segment’s dominant position in the market.

Point-of-care testing is emerging as the fastest-growing end-user segment, driven by the need for rapid diagnostic results and improved clinical efficiency. Veterinary practitioners increasingly value the ability to perform immediate blood analysis during consultations, enabling faster treatment decisions and enhanced patient care. The growing availability of compact, user-friendly analyzers is further accelerating the adoption of point-of-care testing solutions across veterinary settings.

Segment Sub-Segment Largest Segment Fastest Growing
Animal Type Companion Animals, Livestock Animals Companion Animals Companion Animals
Analysis Parameter 3-Part WBC Differential, 5-Part WBC Differential, Others 3-Part WBC Differential 5-Part WBC Differential
End-user Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, Point-of-care Testing, Veterinary Research & Academic Institutes Veterinary Hospitals & Clinics Point-of-care Testing
Product Table-top Analyzers, Fully Automatic Analyzers, Semi-automatic Analyzers, Point-of-care Analyzers, Cartridge Based Analyzers, Direct Sample-Based Analyzers Table-Top Analyzers Point-of-care Analyzers
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the veterinary hematology analyzers market:

  1. IDEXX Laboratories, Inc. (United States)
  2. Zoetis, Inc. (United States)
  3. Sysmex Corporation (Japan)
  4. Horiba Ltd. (Japan)
  5. Boule Diagnostics AB (Sweden)
  6. Heska Corporation (United States)
  7. HemoCue AB (Sweden)
  8. Shenzhen Mindray Animal Medical Technology Co., Ltd. (China)
  9. Siemens Healthineers AG (Germany)

The veterinary hematology analyzers market is evolving as suppliers compete to deliver more accurate diagnostics, streamlined workflows, and solutions tailored to diverse animal healthcare settings. Advancements in automation and diagnostic integration are creating new competitive boundaries, with providers focusing on improving ease of use and supporting faster clinical decision-making. The market is also seeing greater emphasis on systems that combine analytical performance with practical deployment across veterinary practices of varying sizes.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
IDEXX Laboratories Inc. (United States)
Zoetis Inc. (United States)
Sysmex Corporation (Japan)
Horiba Ltd. (Japan)
Boule Diagnostics AB (Sweden)
Heska Corporation (United States)
HemoCue AB (Sweden)
Shenzhen Mindray Animal Medical Technology Co. Ltd. (China)
Siemens Healthineers AG (Germany)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Zoetis Inc. Sep-24 Zoetis Inc. introduced Vetscan OptiCell, a cartridge-based hematology analyzer utilizing artificial intelligence to provide precise Complete Blood Count analysis at the point of care, delivering laboratory-grade results with enhanced time, cost, and space efficiencies for veterinary clinics.
Chengdu Seamaty Technology Co., Ltd. Aug-23 Chengdu Seamaty Technology Co., Ltd. unveiled four veterinary analyzers, including the VBC30 Vet 3-part and VBC50 5-part hematology analyzers, engineered to deliver rapid and accurate Complete Blood Count assessments for clinical diagnostics.
Zoetis Inc. Oct-22 Zoetis Inc. launched its VETSCAN hematology analyzers to facilitate rapid and accessible point-of-care testing, thereby strengthening the company's comprehensive product portfolio within the veterinary diagnostics segment.
IDEXX Laboratories, Inc. Aug-22 IDEXX Laboratories, Inc. launched the ProCyte One Hematology Analyzer, engineered to enhance operational workflow efficiency and deliver accurate diagnostic results directly at the point of care.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Veterinary Hematology Analyzers Market — Custom Segments

Segment Sub-Segment
Reagent Model Open-System Reagents, Closed-System Reagents, Hybrid Reagent Systems
Connectivity Standalone Analyzers, Network-Connected Analyzers, Cloud-Connected Analyzers
Service Model Instrument Sale with Basic Support, Service Contract-Based, Reagent Rental/Placement Model

Veterinary Hematology Analyzers Market — Custom TOC

Custom Chapter Custom Details
Veterinary Diagnostic Workflow Economics
  • Diagnostic Workflow and Testing Intensity
  • In-House Versus Outsourced Testing Economics
  • Labor, Turnaround Time, and Operational Efficiency
  • Analyzer Utilization and Practice-Level Economics
  • Investment Decision Drivers
Analyzer Placement & Utilization Models
  • Placement Models Across Veterinary Practice Settings
  • Instrument Utilization and Throughput Benchmarks
  • Reagent and Consumables Integration
  • Managed-Service and Reagent-Rental Models
Point-of-Care Testing Opportunity Map
  • Point-of-Care Diagnostic Use Cases
  • High-Value Clinical Testing Opportunities
  • Adoption Readiness Across Practice Types
  • Workflow and Technology Integration Priorities
  • Emerging Diagnostic White Spaces

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current revenue of the veterinary hematology analyzers market?

The market valuation of the veterinary hematology analyzers is USD 170.28 Million in 2027.

How is the veterinary hematology analyzers industry size expected to evolve during the forecast period?

Veterinary Hematology Analyzers Market size stood at USD 149.2 Million in 2026 and is predicted to grow at 16.33% CAGR from 2027 to 2036, exceeding USD 677.15 Million by 2036.

How is rising animal healthcare investment reshaping diagnostic equipment adoption?

Increasing spending on companion animal and livestock healthcare is encouraging veterinary providers to invest in automated hematology analyzers that improve diagnostic efficiency, support preventive care, and enable more informed clinical decisions.

Why are veterinary laboratories expanding investments in advanced hematology testing infrastructure?

The growth of diagnostic laboratories and specialty animal hospitals is increasing demand for high-performance analyzers that handle larger testing volumes, improve analytical consistency, and strengthen access to comprehensive veterinary diagnostics.

Why do companion animals dominate demand for veterinary hematology analyzers?

Companion animals accounted for 80.85% share in 2026, driven by rising pet healthcare spending, preventive diagnostics, and increased demand for routine animal health monitoring.

How is point-of-care testing expanding in veterinary diagnostics?

Point-of-care testing is growing as veterinarians seek faster results, improved treatment decisions, and compact analyzers that enhance clinical efficiency.

Why does North America lead the veterinary hematology analyzers market?

North America led in 2026 due to advanced veterinary infrastructure, widespread diagnostic services, automated laboratory adoption, and growing emphasis on preventive animal care.

How is Asia Pacific expected to drive veterinary hematology analyzer growth?

Asia Pacific is projected to grow fastest as pet ownership, veterinary spending, specialized animal hospitals, and automated diagnostic equipment adoption increase.

Which companies are driving growth in the veterinary hematology analyzers landscape?

Key players in the veterinary hematology analyzers market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Sysmex Corporation (Japan), Horiba, Ltd. (Japan), Boule Diagnostics AB (Sweden), Heska Corporation (United States), HemoCue AB (Sweden), Shenzhen Mindray Animal Medical Technology Co., Ltd. (China), Siemens Healthineers AG (Germany)
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →